NYTech
Companies
Company

BranchLab

BranchLab is an AI platform that helps pharmaceutical companies identify, activate, and optimize patient and provider audiences for therapy commercialization[2]. As of June 2026, the company had six open roles available, including positions for a Brand & Marketing Designer, Senior Product Manager for Measurement, Planning & Optimization, and Product Designer[1].

Funding

Key people

Open roles (6)

Recent developments

  • 6 open roles, including Brand & Marketing Designer, Senior Product Manager, Measurement, Planning & Optimization, Product Designer[1]Jun 18, 2026

Alumni 1 went on to found or lead

The full BranchLab mafia →

Funding history

  • BranchLab raised a $26M Series A led by McKesson Ventures with FCA Venture Partners, Sanofi Ventures and AIX Ventures participating, bringing total reported equity funding to $35M. Founded in 2024 by Josh Walsh, Michael Parkes and Chris Cagle.[3]May 14, 2026

Traction

  • BranchLab claims 30x faster campaign execution, 3x higher performance than claims-based targeting, 20x lower CPM than competitive predictive targeting, and a 90% reduction in cost per target audience reached.[5]

Product

  • BranchLab's platform covers patient, HCP and caregiver audience exploration without PHI exposure, AI-driven audience creation and optimization, omnichannel activation across media types, and real-world outcomes measurement. It sells to pharmaceutical manufacturers, advertising agencies, and publishers and platforms.[7]
  • BranchLab builds Pathwai, a unified AI platform for healthcare commercialization that predicts health outcomes from demographic data rather than Protected Health Information, enabling privacy-compliant audience targeting and activation for pharmaceutical marketing.[8]

Customers

  • BranchLab works with leading healthcare agencies including advertising partner Dentsu Health, whose SVP Brad Fox is quoted on the company's site.[6]

Backers

Something wrong or missing? Send a correction. Fixed within 24 hours.